Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Ipca-Gabapentin |
| Active Ingredient: | Gabapentin 100mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Ipca-Gabapentin |
| Active Ingredient: | Gabapentin 300mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Ipca-Gabapentin |
| Active Ingredient: | Gabapentin 400mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Nugabin |
| Active Ingredient: | Gabapentin 100mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Nugabin |
| Active Ingredient: | Gabapentin 300mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Nugabin |
| Active Ingredient: | Gabapentin 400mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
Dated this 3rd day of July 2024.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).